Edward Sherer

Dr. Edward Sherer


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2019 in Science
Verified
Journal Article
Closed access
PDF file
MHMark A. Huffman
Mark A. Huffman
AFAnna Fryszkowska
Anna Fryszkowska
OAOscar Alvizo
Oscar Alvizo
MBMargie Borra-Garske
Margie Borra-Garske
KCKevin R. Campos
Kevin R. Campos
HYHao Yang
Hao Yang
Maximal efficiency from enzyme cascades: Enzymes are highly selective catalysts that can be useful for specific transformations in organic synthesis. Huffman et al. combined designer enzymes in a multistep cascade reaction (see the Perspective by O'Reilly and Ryan). The approach eliminates purification steps, recycles expensive cofactors, and couples favorable and unfavorable reactions. With the target molecule islatravir, an experimental HIV drug, they optimized five enzymes by directed evolution to be compatible with unnatural substrates and stable in the reaction conditions. Stereochemical purity was amplified at every enzymatic step, and the final synthesis was both atom economical and efficient. Science , this issue p. 1255 ; see also p. 1199

16 March 2020 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
PSPatrick J. Sarver
Patrick J. Sarver
VBVlad Bacauanu
Vlad Bacauanu
DSDanielle M. Schultz
Danielle M. Schultz
DDDaniel A. DiRocco
Daniel A. DiRocco
YLYu-Hong Lam
Yu-Hong Lam
DMDavid W. C. MacMillan
David W. C. MacMillan

6 April 2020 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
YXYuting Xu
Yuting Xu
DVDeeptak Verma
Deeptak Verma
RSRobert P. Sheridan
Robert P. Sheridan
ALAndy Liaw
Andy Liaw
JMJunshui Ma
Junshui Ma
JJJennifer M. Johnston
Jennifer M. Johnston

28 April 2017 in Science
Verified
Journal Article
Closed access
PDF file
DDDaniel A. DiRocco
Daniel A. DiRocco
YJYining Ji
Yining Ji
ESEdward Sherer
Edward Sherer
AKArtis Klapars
Artis Klapars
MRMikhail Reibarkh
Mikhail Reibarkh
IDIan W. Davies
Ian W. Davies
Getting phosphorus into healthy shape: ProTide therapeutics play a trick on the body, getting nucleoside analogs where they need to be by decorating them with unnatural phosphoramidates in place of ordinary phosphates. These compounds pose an unusual synthetic challenge because their configuration must be controlled at phosphorus; most methods have been refined to manipulate the geometry of carbon. DiRocco et al. report a metal-free, small-molecule catalyst that attains high selectivity for nucleoside phosphoramidation by activating both reaction partners. Kinetic studies with an early prototype revealed a double role for the catalyst that inspired the rational design of a more active and selective dimeric structure. Science , this issue p. 426

13 August 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ANAleksandra Nilova
Aleksandra Nilova
LCLouis-Charles Campeau
Louis-Charles Campeau
ESEdward Sherer
Edward Sherer
DSDavid Ross Stuart
David Ross Stuart

2 March 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TCTim Cernak
Tim Cernak
NGNathan J. Gesmundo
Nathan J. Gesmundo
KDKevin Dykstra
Kevin Dykstra
YYYang Yu
Yang Yu
ZWZhicai Wu
Zhicai Wu
SDSpencer D. Dreher
Spencer D. Dreher